• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Sanford-Burnham, Pfizer collaborate to speed drug discovery

Sanford-Burnham, Pfizer collaborate to speed drug discovery

June 5, 2013
CenterWatch Staff

Sanford-Burnham Medical Research Institute has partnered with Pfizer as part of Pfizer's focus on translational medicine. The Centers for Therapeutic Innovation (CTI) is Pfizer’s research unit dedicated to establishing global partnerships with academic research institutions.

Working with the CTI unit at Pfizer will provide Sanford-Burnham investigators with access to additional resources including select Pfizer compound libraries, proprietary screening methods and antibody development technologies that are directly relevant to the investigators' work.

"Partnering with Pfizer accelerates our ability to translate our research more quickly into the development of biopharmaceutical products," said Sanford-Burnham chief executive officer John Reed, M.D., Ph.D., professor and Donald Bren chief executive chair.

CTI have been established by Pfizer in New York, Boston, San Francisco and San Diego, where the University of California, San Diego (UCSD) announced its participation in August 2011. Sanford-Burnham is one of only two participating institutions that are not academic medical centers. Given Sanford-Burnham's proximity to UCSD, it is anticipated the Institute will collaborate with UCSD when a project reaches the clinical stage.

The CTI will provide funding to principal investigators for postdoctoral support and provide technical support—including dedicated personnel—in addition to access to infrastructure encompassing laboratory space, chemical libraries, robots, etc.

"Pfizer's CTI program represents a new model for early-stage drug development," said Paul Laikind, Sanford-Burnham's chief business officer, entrepreneur and founder of three startups now publicly traded. "Aggressively working to close the gap between discovery research and clinical application benefits research, benefits patients and ultimately adds to the innovation economy."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing